Ahed Assaf, Suleiman Khaddour, Saja Karaja, William Borghol, Haya Almohammad, Mario Wassel, Kinan Alkeshk, Akram Shammat
{"title":"致死性急性军性结核并发阻塞性黄疸、急性胰腺炎和噬血细胞淋巴组织细胞增多症1例。","authors":"Ahed Assaf, Suleiman Khaddour, Saja Karaja, William Borghol, Haya Almohammad, Mario Wassel, Kinan Alkeshk, Akram Shammat","doi":"10.1186/s13256-025-05558-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Miliary tuberculosis occurs in 2% of all patients with tuberculosis when Mycobacterium tuberculosis circulates in the bloodstream, leading to various nonspecific features. Delayed diagnosis and treatment are associated with poor prognosis and outcomes, with complications becoming life-threatening, making management very challenging for clinicians.</p><p><strong>Case presentation: </strong>A 57-year-old immunocompetent Pakistani female presented with nonspecific features, and further investigations yielded a diagnosis of miliary tuberculosis, accompanied by several rare complications, including pancreatitis, obstructive jaundice, acute respiratory distress syndrome, disseminated intravascular coagulation, hemophagocytic lymphohistiocytosis syndrome, and liver failure. Management was challenging, and the patient subsequently died owing to further derangement in liver function.</p><p><strong>Conclusion: </strong>Miliary tuberculosis may present with nonspecific features and symptoms, and a thorough correlation between clinical examination, radiological findings, and laboratory tests is required to establish the diagnosis. The delayed diagnosis and treatment of miliary tuberculosis majorly affect patient outcomes. The progression of the disease is unpredictable, and several complications, although rare, may occur all at once, emphasizing the importance of multidisciplinary collaboration between specialists. Hemophagocytic lymphohistiocytosis symptoms may overlap with miliary tuberculosis symptoms, and antituberculosis therapy medications are irreplaceable in the treatment of tuberculosis-related hemophagocytic lymphohistiocytosis. Immunocompetence is not a basis for excluding miliary tuberculosis.</p>","PeriodicalId":16236,"journal":{"name":"Journal of Medical Case Reports","volume":"19 1","pages":"466"},"PeriodicalIF":0.8000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12482558/pdf/","citationCount":"0","resultStr":"{\"title\":\"Fatal acute miliary tuberculosis complicated by obstructive jaundice, acute pancreatitis, and hemophagocytic lymphohistiocytosis in a 57-year-old immunocompetent female: a case report.\",\"authors\":\"Ahed Assaf, Suleiman Khaddour, Saja Karaja, William Borghol, Haya Almohammad, Mario Wassel, Kinan Alkeshk, Akram Shammat\",\"doi\":\"10.1186/s13256-025-05558-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Miliary tuberculosis occurs in 2% of all patients with tuberculosis when Mycobacterium tuberculosis circulates in the bloodstream, leading to various nonspecific features. Delayed diagnosis and treatment are associated with poor prognosis and outcomes, with complications becoming life-threatening, making management very challenging for clinicians.</p><p><strong>Case presentation: </strong>A 57-year-old immunocompetent Pakistani female presented with nonspecific features, and further investigations yielded a diagnosis of miliary tuberculosis, accompanied by several rare complications, including pancreatitis, obstructive jaundice, acute respiratory distress syndrome, disseminated intravascular coagulation, hemophagocytic lymphohistiocytosis syndrome, and liver failure. Management was challenging, and the patient subsequently died owing to further derangement in liver function.</p><p><strong>Conclusion: </strong>Miliary tuberculosis may present with nonspecific features and symptoms, and a thorough correlation between clinical examination, radiological findings, and laboratory tests is required to establish the diagnosis. The delayed diagnosis and treatment of miliary tuberculosis majorly affect patient outcomes. The progression of the disease is unpredictable, and several complications, although rare, may occur all at once, emphasizing the importance of multidisciplinary collaboration between specialists. Hemophagocytic lymphohistiocytosis symptoms may overlap with miliary tuberculosis symptoms, and antituberculosis therapy medications are irreplaceable in the treatment of tuberculosis-related hemophagocytic lymphohistiocytosis. Immunocompetence is not a basis for excluding miliary tuberculosis.</p>\",\"PeriodicalId\":16236,\"journal\":{\"name\":\"Journal of Medical Case Reports\",\"volume\":\"19 1\",\"pages\":\"466\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2025-09-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12482558/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Medical Case Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s13256-025-05558-8\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s13256-025-05558-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Fatal acute miliary tuberculosis complicated by obstructive jaundice, acute pancreatitis, and hemophagocytic lymphohistiocytosis in a 57-year-old immunocompetent female: a case report.
Background: Miliary tuberculosis occurs in 2% of all patients with tuberculosis when Mycobacterium tuberculosis circulates in the bloodstream, leading to various nonspecific features. Delayed diagnosis and treatment are associated with poor prognosis and outcomes, with complications becoming life-threatening, making management very challenging for clinicians.
Case presentation: A 57-year-old immunocompetent Pakistani female presented with nonspecific features, and further investigations yielded a diagnosis of miliary tuberculosis, accompanied by several rare complications, including pancreatitis, obstructive jaundice, acute respiratory distress syndrome, disseminated intravascular coagulation, hemophagocytic lymphohistiocytosis syndrome, and liver failure. Management was challenging, and the patient subsequently died owing to further derangement in liver function.
Conclusion: Miliary tuberculosis may present with nonspecific features and symptoms, and a thorough correlation between clinical examination, radiological findings, and laboratory tests is required to establish the diagnosis. The delayed diagnosis and treatment of miliary tuberculosis majorly affect patient outcomes. The progression of the disease is unpredictable, and several complications, although rare, may occur all at once, emphasizing the importance of multidisciplinary collaboration between specialists. Hemophagocytic lymphohistiocytosis symptoms may overlap with miliary tuberculosis symptoms, and antituberculosis therapy medications are irreplaceable in the treatment of tuberculosis-related hemophagocytic lymphohistiocytosis. Immunocompetence is not a basis for excluding miliary tuberculosis.
期刊介绍:
JMCR is an open access, peer-reviewed online journal that will consider any original case report that expands the field of general medical knowledge. Reports should show one of the following: 1. Unreported or unusual side effects or adverse interactions involving medications 2. Unexpected or unusual presentations of a disease 3. New associations or variations in disease processes 4. Presentations, diagnoses and/or management of new and emerging diseases 5. An unexpected association between diseases or symptoms 6. An unexpected event in the course of observing or treating a patient 7. Findings that shed new light on the possible pathogenesis of a disease or an adverse effect